PASITHEA THERAPEUTICS CORP. Increase (Decrease) in Derivative Liabilities
PASITHEA THERAPEUTICS CORP. (KTTA) reported Increase (Decrease) in Derivative Liabilities of $46.87 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2023-05-12
- PASITHEA THERAPEUTICS CORP. increase (decrease) in derivative liabilities for the quarter ending 2023-03-31 was $46.87K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in derivative liabilities for the quarter ending 2022-12-31 was -$980.51K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in derivative liabilities for the quarter ending 2022-03-31 was -$785.30K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in derivative liabilities for the quarter ending 2021-12-31 was -$2.59M.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in derivative liabilities for fiscal 2022 was -$1.85M.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in derivative liabilities for fiscal 2021 was -$2.33M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2023-03-31 | $46.87K 10-Q · filed 2023-05-12 | -$933.64K derived: sum of 2 quarters · filed 2023-05-12 | ||
| 2022-12-31 | -$980.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.85M 10-K · filed 2023-03-30 | ||
| 2022-09-30 | -$871.68K 10-Q · filed 2022-11-14 | |||
| 2022-03-31 | -$785.30K 10-Q · filed 2023-05-12 | -$3.37M derived: sum of 2 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$2.33M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $252.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |